Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
CN Energy Group A | CNEY | Nov 26, 2024 | 0.38 | +10.97 |
CNA Financial | CNA | Nov 26, 2024 | 50.00 | +0.56 |
CNB Financial | CCNE | Nov 26, 2024 | 28.26 | -0.42 |
CNB Financial Pref | CCNEP | Nov 26, 2024 | 24.70 | -1.00 |
CNFinance ADR | CNF | Nov 26, 2024 | 0.95 | -4.02 |
CNH Industrial N.V. | CNH | Nov 26, 2024 | 12.38 | -2.13 |
CNO Financial Group | CNO | Nov 26, 2024 | 40.50 | +0.42 |
CNS Pharmaceuticals | CNSP | Nov 26, 2024 | 0.12 | +1.22 |
CNX Resources | CNX | Nov 26, 2024 | 40.78 | +0.92 |
Co-Diagnostics | CODX | Nov 26, 2024 | 0.93 | -6.06 |
CO2 Energy Transition Unit | NOEMU | Nov 26, 2024 | 9.98 | 0.00 |
Coastal Financial | CCB | Nov 26, 2024 | 77.30 | -0.88 |
Coca-Cola | KO | Nov 26, 2024 | 64.55 | +0.26 |
Coca-Cola Consolidated | COKE | Nov 26, 2024 | 1 344.96 | +3.49 |
Coca-Cola Europacific Partners | CCEP | Nov 26, 2024 | 77.94 | -0.26 |
Coca-Cola FEMSA ADR | KOF | Nov 26, 2024 | 79.17 | -1.11 |
Cocrystal Pharma | COCP | Nov 26, 2024 | 2.12 | -2.30 |
Coda Octopus | CODA | Nov 26, 2024 | 9.02 | -3.84 |
Codere Online Luxembourg | CDRO | Nov 26, 2024 | 7.83 | +1.42 |
Codexis | CDXS | Nov 26, 2024 | 4.56 | +0.22 |
Coeptis Therapeutics | COEP | Nov 26, 2024 | 0.19 | -2.43 |
Coeur Mining | CDE | Nov 26, 2024 | 6.38 | +1.27 |
Coffee Holding Company | JVA | Nov 26, 2024 | 3.41 | -2.01 |
Cogent Biosciences | COGT | Nov 26, 2024 | 9.63 | +4.73 |
Cogent Communications | CCOI | Nov 26, 2024 | 82.50 | -0.63 |
Cognex | CGNX | Nov 26, 2024 | 40.24 | -3.11 |
Cognition Therapeutics | CGTX | Nov 26, 2024 | 0.40 | -0.61 |
Cognizant Technology Solutions A | CTSH | Nov 26, 2024 | 81.06 | +0.53 |
Cognyte Software | CGNT | Nov 26, 2024 | 7.93 | -0.25 |
Cohen & Company | COHN | Nov 26, 2024 | 10.15 | +2.63 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.